Bafna Pharmaceuticals Announcements
Significant movement in price has been observed in Bafna Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the...
15 Apr, 2026 | 11:20am • Source: NSE
The Exchange has sought clarification from Bafna Pharmaceuticals Ltd on April 13, 2026 with reference to significant movement in price, in order to ensure that...
13 Apr, 2026 | 07:33pm • Source: BSE
Certificate under Regulation 74(5) of SEBi (DP) Regulations, 2018 for the Quarter ended March 31, 2026.
13 Apr, 2026 | 03:45pm • Source: BSE
The Board of Directors of the Company in the Meeting held on March 27, 2026 has inter-alia considered and approved: (i) The appointment of M/s....
27 Mar, 2026 | 01:12pm • Source: BSE
Intimation for Closure of Trading Window.
26 Mar, 2026 | 02:59pm • Source: BSE
We hereby submit our response to the clarification sought by the Stock Exchange regarding the movement in the share price of the Company.
24 Mar, 2026 | 11:49am • Source: BSE
The Exchange has sought clarification from Bafna Pharmaceuticals Ltd on March 23, 2026 with reference to significant movement in price, in order to ensure that...
23 Mar, 2026 | 05:57pm • Source: BSE
Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and...
05 Feb, 2026 | 03:11pm • Source: BSE
We hereby inform you that the Outlook of the Credit Ratings assigned to the Bank loan facilites of the Company has been revised by ICRA...
23 Jan, 2026 | 07:02pm • Source: BSE
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended December 31, 2025.
09 Jan, 2026 | 03:21pm • Source: BSE
Intimation for Closure of Trading Window.
26 Dec, 2025 | 12:28pm • Source: BSE
We hereby enclose the Newspaper publication of the extract of the Unaudited Financial Results of the Company for the Quarter and Half Year ended September...
14 Nov, 2025 | 05:16pm • Source: BSE
The Board of Directors of the Company in the Meeting held on November 11, 2025 has inter-alia considered and approved the Unaudited Financial Results of...
11 Nov, 2025 | 05:32pm • Source: BSE
The Board of Directors of the Compant in the meeting held on November 11, 2025 has inter-alia considered and approved the Unaudited Financial Results of...
11 Nov, 2025 | 05:22pm • Source: BSE
Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and...
06 Nov, 2025 | 11:43am • Source: BSE
Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended September 30, 2025
10 Oct, 2025 | 12:27pm • Source: NSE
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended September 30, 2025.
10 Oct, 2025 | 12:17pm • Source: BSE
Intimation for Closure of Trading Window
26 Sep, 2025 | 03:06pm • Source: BSE
We hereby inform that the Members at the 30th Annual General Meeting of the Company held on September 19, 2025 had inter-alia approved (i) Appointment...
19 Sep, 2025 | 06:38pm • Source: BSE
We hereby inform that the Members at the 30th Annual General Meeting of the Company held on September 19, 2025 had inter-alia approved (i) Appointment...
19 Sep, 2025 | 06:33pm • Source: BSE